首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1619126

器官晶片市場規模、佔有率、成長分析，按器官類型、按模型類型、按產品、按用途、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Organ On Chip Market Size, Share, Growth Analysis, By Organ Type (Liver, Kidney), By Model Type (Organ-Based Models, Disease-Based Models), By Product, By Purpose, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月19日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球器官晶片市場規模將達到1.2億美元，從2023年的1.6224億美元成長到2031年的18.1122億美元，預計在預測期內（2024-2031年）將以年複合成長率成長。。

由於技術進步以及製藥、生物技術和學術領域的採用不斷增加，以及對動物試驗替代方案的需求以及早期檢測藥物反應的需求的推動，器官晶片市場正在經歷快速成長。這種微流體細胞培養裝置模擬器官功能，並在疾病建模、藥物設計和毒性測試中提供多種應用。值得注意的是，最近向國際太空站國家實驗室發送的 Emulate 腦晶片等成果凸顯了該技術的創新潛力。隨著相關人員尋求擴大醫療機構中的器官應用，後 COVID-19 情況進一步強化了這一需求。因此，全球器官晶片市場預計在預測期內將以 30.76% 的年複合成長率成長，重塑藥物開發和調查方法。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

Emulate, Inc.
Mimetas BV
Tissuse GmbH
CN Bio Innovations Ltd.
InSphero
Alveolix AG
Fluigent

結論和建議

簡介目錄

Product Code: SQMIG35A2896

Global Organ On Chip Market size was valued at USD 120.0 million in 2022 and is poised to grow from USD 162.24 million in 2023 to USD 1811.22 million by 2031, growing at a CAGR of 35.2% during the forecast period (2024-2031).

The organ-on-a-chip market is witnessing rapid growth due to technological advancements and increased adoption across pharmaceutical, biotechnology, and academic sectors, driven by the demand for alternatives to animal testing and the need for early drug reaction detection. This microfluidic cell culture device simulates organ functions and offers diverse applications in disease modeling, drug design, and toxicity testing. Notably, recent initiatives, such as Emulate, Inc.'s Brain Chip sent to the ISS National Lab, highlight the technology's innovative potential. The post-COVID-19 landscape has further intensified this demand, as stakeholders aim to expand organ applications within healthcare settings. Consequently, the global organ-on-a-chip market is projected to grow at a remarkable CAGR of 30.76% during the forecast period, reshaping drug development and research methodologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Organ On Chip market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Organ On Chip Market Segmental Analysis

Global Organ On Chip Market is segmented by organ type, model type, product, purpose, application, end user and region. Based on organ type, the market is segmented into liver, kidney, intestine, lung, heart and other organs. Based on model type, the market is segmented into organ-based models and disease-based models. Based on product, the market is segmented into services and products. Based on purpose, the market is segmented into therapeutics and research. Based on application, the market is segmented into toxicology research, drug discovery, physiological model development, tissue regeneration & regenerative medicine and stem cell research. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, cosmetics industry, academic & research institutes and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Organ On Chip Market

The Global Organ-On-Chip market is significantly driven by the growing demand for animal-free testing solutions. As awareness regarding ethical considerations and animal welfare continues to increase among consumers globally, there is a strong advocacy for alternatives to traditional testing methods. Organ-on-chip technologies are emerging as vital tools in drug discovery and toxicity assessments, offering reliable and humane options for researchers. This shift towards innovative, non-animal testing platforms is likely to provide substantial momentum to the market, as organizations seek to align with consumer preferences while enhancing the efficiency and accuracy of their scientific evaluations.

Restraints in the Global Organ On Chip Market

The Global Organ-On-Chip market faces significant restraints due to various ethical and societal challenges. Chief among these concerns are the ethical implications related to the use of human cells, tissues, and organs in research, which raise questions about informed consent, privacy, and the ethical sourcing of biological materials. It is crucial to navigate these ethical, legal, and societal issues responsibly, particularly regarding animal welfare. Addressing these challenges is vital for fostering sustainable growth and development in the market, as stakeholders must ensure that their practices align with ethical standards while promoting innovation and accessibility in organ-on-chip technology.

Market Trends of the Global Organ On Chip Market

The Global Organ-On-Chip market is witnessing a notable trend towards enhancing the accuracy of drug predictions, driven by escalating R&D costs and waning effectiveness in pharmaceuticals. As drug development faces critical challenges, companies are increasingly adopting organ-on-chip technologies to simulate human organ responses accurately, thereby reducing dependence on traditional animal testing. This innovative approach not only streamlines the drug development process but also improves safety assessments and efficacy predictions. The growing demand for personalized medicine and regulatory pressure for better predictive models further propels market growth, positioning organ-on-chip solutions as a pivotal tool for the future of pharmaceutical research and development.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Case Study Analysis
Trade Analysis
Customer & Buying Criteria Analysis

Global Organ On Chip Market Size by Organ Type & CAGR (2024-2031)

Market Overview
Liver
Kidney
Intestine
Lung
Heart
Other Organs

Global Organ On Chip Market Size by Model Type & CAGR (2024-2031)

Market Overview
Organ-Based Models
Disease-Based Models

Global Organ On Chip Market Size by Product & Service & CAGR (2024-2031)

Market Overview
Services
- Custom Services
- Standard Services
Products
- Instruments
- Consumables & Accessories
- Software

Global Organ On Chip Market Size by Purpose & CAGR (2024-2031)

Market Overview
Therapeutics
Research

Global Organ On Chip Market Size by Application & CAGR (2024-2031)

Market Overview
Toxicology Research
Drug Discovery
Physiological Model Development
Tissue Regeneration & Regenerative Medicine
Stem Cell Research

Global Organ On Chip Market Size by End User & CAGR (2024-2031)

Market Overview
Pharmaceutical and Biotechnology Companies
Cosmetics Industry
Academic & Research Institutes
Other End Users

Global Organ On Chip Market Size & CAGR (2024-2031)

North America (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- US
- Canada
Europe (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Emulate, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mimetas B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissuse GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CN Bio Innovations Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InSphero
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alveolix AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluigent
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments